RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma

Bo Zhao(The Wistar Institute)
Research Square
July 8, 2022
Cited by 0


Related Papers